title: Effects of methylphenidate on EEG coherence in attention-deficit/hyperactivity disorder.
abstract: This study investigated the effects of methylphenidate on intrahemispheric and interhemispheric EEG coherence in children with Attention-Deficit/Hyperactivity Disorder (AD/HD). Twenty boys with AD/HD Combined type and 20 age- and sex-matched control subjects, aged 8 to 13 years, participated in this study. EEG was recorded from 21 sites during an eyes-closed resting condition. Wave-shape coherence was calculated for eight intrahemispheric electrode pairs (four in each hemisphere), and eight interhemispheric electrode pairs, within each of the delta, theta, alpha and beta bands. AD/HD children were tested both off and, 6 months later, on a therapeutic dose of methylphenidate. In intrahemispheric comparisons, AD/HD children had lower theta coherences at long inter-electrode distances, and reduced lateralisation at both long and short-medium inter-electrode distances than controls. For interhemispheric comparisons, AD/HD children showed increased coherences in the frontal regions for the low frequency bands (delta and theta), and reduced coherences in the alpha bands in all other regions. These EEG coherences suggest reduced cortical differentiation and specialisation in AD/HD, particularly in the frontal regions. Methylphenidate did not produce any changes in coherence values. The lack of sensitivity of coherence measures to methylphenidate in the present study suggests that eyes-closed resting EEG coherence measures are associated with structural connectivity of the underlying regions of the brain rather than the degree of functionality of these regions. These results suggest the existence of structural as well as functional brain dysfunction in AD/HD.
authors.affiliation: Brain & Behaviour Research Institute and Department of Psychology, University of Wollongong, Wollongong 2522, Australia. ADAM_CLARKE@UOW.EDU.AU
authors.forename: Adam R
authors.initials: AR
authors.lastname: Clarke
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Barry
authors.forename: Rory
authors.initials: R
authors.lastname: McCarthy
authors.forename: Mark
authors.initials: M
authors.lastname: Selikowitz
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Johnstone
authors.forename: Isis
authors.initials: I
authors.lastname: Abbott
authors.forename: Rodney J
authors.initials: RJ
authors.lastname: Croft
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Magee
authors.forename: Ching-I
authors.initials: CI
authors.lastname: Hsu
authors.forename: Carlie A
authors.initials: CA
authors.lastname: Lawrence
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000502:physiology; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D002648:Child; D004569:Electroencephalography / Q000187:drug effects*; D007839:Functional Laterality / Q000187:drug effects; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage*
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate